Loading...
Please wait, while we are loading the content...
NEDD9 depletion leads to MMP14 inactivation by TIMP2 and prevents invasion and metastasis.
| Content Provider | Semantic Scholar |
|---|---|
| Author | McLaughlin, Sarah L. Ice, Ryan Joseph Rajulapati, Anuradha Kozyulina, Polina Yu. Livengood, Ryan H. Kozyreva, Varvara K. Loskutov, Yuriy V. Culp, Mark Vere Weed, Scott A. Ivanov, Alexandr Vladimirovich Pugacheva, Elena N. |
| Copyright Year | 2014 |
| Abstract | UNLABELLED The scaffolding protein NEDD9 is an established prometastatic marker in several cancers. Nevertheless, the molecular mechanisms of NEDD9-driven metastasis in cancers remain ill-defined. Here, using a comprehensive breast cancer tissue microarray, it was shown that increased levels of NEDD9 protein significantly correlated with the transition from carcinoma in situ to invasive carcinoma. Similarly, it was shown that NEDD9 overexpression is a hallmark of highly invasive breast cancer cells. Moreover, NEDD9 expression is crucial for the protease-dependent mesenchymal invasion of cancer cells at the primary site but not at the metastatic site. Depletion of NEDD9 is sufficient to suppress invasion of tumor cells in vitro and in vivo, leading to decreased circulating tumor cells and lung metastases in xenograft models. Mechanistically, NEDD9 localized to invasive pseudopods and was required for local matrix degradation. Depletion of NEDD9 impaired invasion of cancer cells through inactivation of membrane-bound matrix metalloproteinase MMP14 by excess TIMP2 on the cell surface. Inactivation of MMP14 is accompanied by reduced collagenolytic activity of soluble metalloproteinases MMP2 and MMP9. Reexpression of NEDD9 is sufficient to restore the activity of MMP14 and the invasive properties of breast cancer cells in vitro and in vivo. Collectively, these findings uncover critical steps in NEDD9-dependent invasion of breast cancer cells. IMPLICATIONS This study provides a mechanistic basis for potential therapeutic interventions to prevent metastasis. |
| Starting Page | 69 |
| Ending Page | 81 |
| Page Count | 13 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://mcr.aacrjournals.org/content/molcanres/early/2013/11/07/1541-7786.MCR-13-0300.full.pdf |
| PubMed reference number | 24202705v1 |
| Alternate Webpage(s) | https://doi.org/10.1158/1541-7786.MCR-13-0300 |
| DOI | 10.1158/1541-7786.mcr-13-0300 |
| Journal | Molecular cancer research : MCR |
| Volume Number | 12 |
| Issue Number | 1 |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Endopeptidases Invasive Carcinoma MMP14 gene MMP14 protein, human MMP2 gene Malignant Neoplasms Mammary Neoplasms Matrix Metalloproteinase 9 Matrix Metalloproteinases Metalloproteases NEDD9 gene Neoplasm Metastasis Scaffold protein Tissue Microarray Tissue membrane Xenograft type of graft cancer cell lung metastases |
| Content Type | Text |
| Resource Type | Article |
